Insights Hub

News

Propath presents a new approach for AI-driven ROI selection for GeoMx DSP analysis at SITC 2023

Working with our partners at Visiopharm and NanoString, the team at Propath UK have today published a poster at SITC 2023 demonstrating a new approach to streamline the workflow for ROI/AOI selection on GeoMx® DSP slides.

Taking spatial transcriptomics to the next level: Propath UK launches NanoString CosMx single-cell spatial analysis as a commercial service

The CosMx is a powerful new platform for spatial transcriptomics and proteomics, providing high-plex in-situ analysis at cellular and subcellular resolution. The platform enables researchers to investigate morphologically-intact tissues at unprecedented plex, resolution and cell numbers.

Propath partners with Lunaphore to offer hyper-plex immunofluorescence staining

Propath and Lunaphore form partnership to offer hyper-plex spatial proteomics

Investment in Spatial Biology: Propath appoints new Chief Scientific Officer to lead Propath’s services in spatial proteomics and transcriptomics

Propath UK appoints new Chief Scientific Officer to lead services in spatial proteomics and transcriptomics

Propath completes spatial analysis of the whole transcriptome using the NanoString GeoMx

Advancing spatial transcriptomics: Propath completes spatial analysis of the whole transcriptome using the NanoString GeoMx.

Propath to launch grant programme for Nanostring's new Antibody Drug Conjugate development panel.

As as an established partner of NanoString, Propath launches a new grant programme for researchers developing therapeutics based on antibody drug conjugates.

Propath partners with NanoString to bring the GeoMx Cancer Transcriptome Atlas to Europe

Propath announces that it now offers a turn-key service to run the NanoString GeoMx Cancer Transcriptome Atlas assay for spatial profiling of 1,800 genes on single clinical or experimental samples.

COVID-19 pathogenesis and host response: nCounter gene expression of COVID-19 samples

Propath and NanoString have come together to launch a grant programme for researchers exploring the pathogenesis and host response of SARs-CoV-2

Sign up to our newsletter

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Morbi bibendum, pellentesque quam id, bibendum sapien.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Outsourced R&D - Done better.

At Propath we approach biopharma R&D differently. Say goodbye to Large CRO frustrations –and hello to a more responsive, agile and efficient level of service.

Schedule a call Get in touch